Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Projected to Grow at 14.6% CAGR, Reaching $12.13 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Industry Market Size Be by 2025?
The continuous glucose monitoring (CGM) patch sector, which monitors blood glucose levels in real time, has experienced swift expansion lately; this market is projected to increase its valuation from $6.12 billion in 2024 up to $7.04 billion the following year, reflecting a compound annual growth rate (CAGR) of 15.0%.Factors driving this expansion during the past period include wider availability of insurance coverage, a robust foundation of clinical proof, increased proficiency and understanding among healthcare providers, a trend favoring chronic condition management within home settings, and official recognition within established professional protocols.

What's the Long-Term Growth Forecast for the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Size Through 2029?
Anticipation surrounds the continuous glucose monitoring (CGM) patch sector for real-time blood monitoring, projecting substantial expansion; this market is slated to attain a valuation of $12.14 billion by 2029, exhibiting a compound annual growth rate of 14.6%. This upward trajectory throughout the projection timeframe is fueled by several factors: heightened efforts in screening for prediabetes and achieving diagnoses sooner, broader inclusion in coverage for individuals both using and not using insulin, incentives tied to value-based care models focusing on time in range metrics, the increasing prevalence of older demographics grappling with greater metabolic health challenges, and the influence of urbanization alongside evolving dietary habits in developing nations. Key developments anticipated during this period encompass patch sensors designed for longer application durations exceeding a fortnight, the synergy between automated insulin delivery systems and patch-based CGM technology, the development of direct connections to wrist-worn devices bypassing the need for a smartphone, advancements in subtle, on-body vibration alerts, and the utilization of superior biocompatible adhesives engineered to minimize skin sensitivity.

View the full report here:
https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report

What Are the Key Growth Drivers Fueling the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Expansion?
The escalating incidence of diabetes is foreseen to be a major impetus for the advancement of the continuous glucose monitoring (CGM) patch sector specifically designed for real-time blood glucose tracking in the future. Diabetes, fundamentally a long-term metabolic condition marked by persistently high blood sugar resulting from either inadequate insulin creation or the body's inability to utilize the insulin it produces, is becoming more common; this increase is largely attributable to the growing rates of obesity, which in turn escalates insulin resistance, thereby upsetting the body's blood sugar control systems and substantially heightening the likelihood of developing type 2 diabetes. Real-time CGM patches empower diabetic individuals by allowing for uninterrupted, moment-by-moment observation of their glucose concentrations, furnishing prompt notifications during instances where sugar levels are either too high or too low, thus facilitating prompt modifications to diet, drug regimens, and daily habits, which culminates in superior overall condition handling and a diminished chance of associated health problems; to illustrate this point, the UK's National Health Service reported in June 2024 that, as of 2023, over half a million (specifically 549,000) further people in England were identified as being vulnerable to developing type 2 diabetes, expanding the count of patients documented with pre-diabetes-or non-diabetic hyperglycemia-to 3,615,330 within GP records, a notable jump from the 3,065,825 recorded in 2022, signifying an almost 20 percent climb, which underlines precisely why the expanding diabetic population is fueling the expansion of the market for real-time CGM patches.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29166&type=smp

What Are the Key Trends Driving Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Growth?
Dominant players within the continuous glucose monitoring (CGM) patch sector, which focuses on real-time blood glucose tracking, are heavily investing in creating novel solutions, notably over-the-counter CGM sensors, with the aim of broadening availability and enhancing user ease. These prescription-free, wearable devices continuously measure glucose concentrations, enabling individuals to monitor their levels constantly, gain insight into how daily activities influence those numbers, and ultimately simplify diabetes management or proactive prevention strategies. Illustratively, in September of 2024, Dexcom Inc., an American firm specializing in diabetes technology, introduced Stelo, marking its inaugural over-the-counter CGM patch within the US market. This compact sensor adheres to the back of the upper arm, streaming live glucose data straight to a companion mobile application, thereby eliminating the necessity for finger-pricking tests. Intended for individuals managing Type 2 diabetes who are not dependent on insulin, alongside those classified as having prediabetes, Stelo furnishes customized analytics detailing the impact of nourishment, physical activity, and slumber on glucose metrics. Sporting a wear duration of up to two weeks, water resistance capabilities, detection for fluctuations and recurring patterns, and employing Dexcom's established glucose sensing science, this equipment significantly boosts the accessibility, convenience, and utility of continuous glucose surveillance for a wider demographic.

How Is the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Segmented?
The real-time blood glucose continuous glucose monitoring (cgm) patchmarket covered in this report is segmented -

1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch
2) By Technology: Enzymatic, Non-Enzymatic
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications
5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users

Subsegments:
1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch, Telehealth-Compatible Wearable Continuous Glucose Monitoring (CGM) Patch
2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch, Remote-Monitoring Implantable Continuous Glucose Monitoring (CGM) Patch

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=29166&type=smp

Which Companies Are Leading the Charge in Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Innovation?
Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic plc, Dexcom Inc., Trinity Biotech plc, Biolinq Inc., Ascensia Diabetes Care Holdings AG, Senseonics Holdings Inc., A. Menarini Diagnostics S.r.l., RSP Systems A/S, OrSense Ltd., Rockley Photonics Holdings Ltd., Sinocare Inc., CNOGA Medical Ltd., Medtrum Technologies Inc., Nutromics Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Movano Health Inc., and GlucoRx Ltd.

Which Regions Are Leading the Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market in Revenue?
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=29166

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.